The impact of prostate volume estimation on the risk-adapted biopsy decision based on prostate-specific antigen density and magnetic resonance imaging score.

Baudewyns A, Guenzel K, Halinski A, Dariane C, Delavar G, Anract J, Barry Delongchamps N, Jabbour T, Bourgeno HA, Lefebvre Y, Ferriero M, Simone G, Fourcade A, Fournier G, Oderda M, Gontero P, Bernal-Gomez A, Mastrorosa A, Roche JB, Zahr RA, Ploussard G, Fiard G, Rysankova K, Bui AP, Taha F, Windisch O, Benamran D, Vlahopoulos L, Assenmacher G, Roumeguère T, Peltier A, Diamand R